Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
9 Opportunity Way , Newburyport, MA, 01950, US
CellProthera will tech transfer to CELLforCURE by SEQENS this year, with plans to produce clinical batches starting in 2026.
By: Rachel Klemovitch
Villemagne previously served as CEO of Carbogen Amcis.
By: Charlie Sternberg
SEQENS will produce the active ingredient in Sarconeos (BIO101) in France at its Villeneuve La Garenne plant.
By: Anthony Vecchione
Luzeau discusses expansion into U.S. markets, outsourcing trends, and the company’s plan for continued growth in the CDMO space.
By: Kristin Brooks
Invests $5 million in a state-of-the-art, 15,000 sq.-ft. R&D center in Devens, MA.
Increases R&D capability and productivity in the U.S. and builds on merger with CDMO Wavelength Pharmaceuticals.
CDMO Seqens to provide clinical and commercial supply of MMS019.
By: Tim Wright
Jean-Noel David was previously a VP at Patheon Biologics.
By: Contract Pharma
Will produce highly active ingredients at its Villeneuve-La-Garenne site.
Seqens’ Lab to add GMP pilot plant by end of 2020
SEQENS'Lab is a development accelerator located just out of Paris
The name change comes six months after PCI Synthesis was acquired by Novacap
By: Betsy Louda
Expands pharma offering in the U.S.
PCI Synthesis shares expected trends in the industry within the next year
The new addition has over twenty years of industry experience, and will be based out of California
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
